Alpine Immune Sciences, Inc. Profile Avatar - Palmy Investing

Alpine Immune Sciences, Inc.

Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline i…

Biotechnology
US, Seattle [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

Alpine Immune Sciences, Inc. can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

Alpine Immune Sciences, Inc. can't present revenue by segment

Get PRO Today

With PRO you can bypass the blur for the segment revenues of Alpine Immune Sciences, Inc..

If you want to see a demo, head over to the financial segments of AAPL

End of ALPN's Analysis
CIK: 1626199 CUSIP: 02083G100 ISIN: US02083G1004 LEI: - UEI: -
Secondary Listings
ALPN has no secondary listings inside our databases.